Cellid Co. Ltd (299660) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.031x

Based on the latest financial reports, Cellid Co. Ltd (299660) has a cash flow conversion efficiency ratio of -0.031x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.30 Billion ≈ $-1.56 Million USD) by net assets (₩74.21 Billion ≈ $50.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 299660 stock market capitalisation for the company's overall valuation and market capitalisation.

Cellid Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Cellid Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cellid Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cellid Co. Ltd ranked by their cash flow conversion efficiency. Explore 299660 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Hindustan Motors Limited NSE:HINDMOTORS	-0.844x
Rothwell International Co. Limited KQ:900260	0.415x
Caprice Resources Ltd AU:CRS	-0.023x
Rama Phosphates Limited NSE:RAMAPHO	0.011x
Hoa Tho Textile - Garment Joint Stock Corp VN:HTG	N/A
Sinsin Pharmaceutical Co. Ltd KQ:002800	0.066x
Strongpoint ASA OL:STRO	0.061x
FreeCast, Inc. Class A Common Stock NASDAQ:CAST	0.408x

Annual Cash Flow Conversion Efficiency for Cellid Co. Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Cellid Co. Ltd from 2016 to 2025. View latest Cellid Co. Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩74.21 Billion ≈ $50.29 Million	₩-10.22 Billion ≈ $-6.92 Million	-0.138x	+31.65%
2024-12-31	₩51.20 Billion ≈ $34.70 Million	₩-10.32 Billion ≈ $-6.99 Million	-0.201x	-14.66%
2023-12-31	₩40.50 Billion ≈ $27.44 Million	₩-7.12 Billion ≈ $-4.82 Million	-0.176x	+67.73%
2022-12-31	₩22.44 Billion ≈ $15.21 Million	₩-12.22 Billion ≈ $-8.28 Million	-0.544x	-157.14%
2021-12-31	₩38.76 Billion ≈ $26.27 Million	₩-8.21 Billion ≈ $-5.56 Million	-0.212x	-166.09%
2020-12-31	₩47.30 Billion ≈ $32.05 Million	₩-3.76 Billion ≈ $-2.55 Million	-0.080x	-112.62%
2019-12-31	₩51.33 Billion ≈ $34.79 Million	₩-1.92 Billion ≈ $-1.30 Million	-0.037x	+74.67%
2018-12-31	₩13.50 Billion ≈ $9.15 Million	₩-1.99 Billion ≈ $-1.35 Million	-0.148x	-159.53%
2017-12-31	₩-5.53 Billion ≈ $-3.75 Million	₩-1.37 Billion ≈ $-929.53K	0.248x	-96.60%
2016-12-31	₩-205.83 Million ≈ $-139.49K	₩-1.50 Billion ≈ $-1.02 Million	7.306x	--

About Cellid Co. Ltd

KQ:299660 Korea Biotechnology

Market Cap

$46.19 Million

₩68.15 Billion KRW

Market Cap Rank

#22280 Global

#1413 in Korea

Share Price

₩2310.00

Change (1 day)

+1.32%

52-Week Range

₩1025.00 - ₩4110.00

All Time High

₩127128.20